Caribou Biosciences (CRBU) Operating Income Growth (1y) (2021 - 2026)
Caribou Biosciences (CRBU) Operating Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | 1,386.07% |
| 10 | Caribou Biosciences | 153.86 Mn | 36.23 Mn | - | 38.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.76% |
| Dec 31, 2025 | 26.81% |
| Sep 30, 2025 | 23.11% |
| Jun 30, 2025 | -9.37% |
| Mar 31, 2025 | 6.71% |
| Dec 31, 2024 | -3.83% |
| Sep 30, 2024 | -161.31% |
| Jun 30, 2024 | -32.35% |
| Mar 31, 2024 | -47.84% |
| Dec 31, 2023 | -22.45% |
| Sep 30, 2023 | 44.86% |
| Jun 30, 2023 | -15.61% |
| Mar 31, 2023 | -49.22% |
| Dec 31, 2022 | -49.86% |
| Sep 30, 2022 | -42.55% |
| Jun 30, 2022 | -78.09% |
| Mar 31, 2022 | -58.28% |
| Dec 31, 2021 | -34.15% |
| Sep 30, 2021 | -126.22% |
| Jun 30, 2021 | -607.94% |